FimasaRtan-basEd BP Targets After Drug SwitcHing

Clinical trial NCT03649646 · COMPLETED

Trial details

NCT number: NCT03649646
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Essential Hypertension

Start date: 2018-07-03
Primary completion: 2020-10-29
Enrollment: 4542

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.